Paper16670409
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
Anton RF and 20 others. JAMA, 2006. Cited by 1,299 papers, by iCite.
Cite this record
ConductScience Library. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. Papers, record 16670409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16670409
- Disease
- alcohol dependence125 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alcohol Deterrents | Major topic |
| Alcoholism | Major topic |
| Behavior Therapy | Major topic |
| Naltrexone | Major topic |
| Narcotic Antagonists | Major topic |
| Taurine | Major topic |
| Acamprosate | |
| Adult | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Placebo Effect |
Source PubMed
Grants16
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 11716 | PHS HHS | United States | PubMed | PubMed | |
| 11721 | PHS HHS | United States | PubMed | PubMed | |
| 11727 | PHS HHS | United States | PubMed | PubMed | |
| 11756 | PHS HHS | United States | PubMed | PubMed | |
| 11768 | PHS HHS | United States | PubMed | PubMed | |
| 11773 | PHS HHS | United States | PubMed | PubMed | |
| 11776 | PHS HHS | United States | PubMed | PubMed | |
| 11777 | PHS HHS | United States | PubMed | PubMed | |
| 11783 | PHS HHS | United States | PubMed | PubMed | |
| 11787 | PHS HHS | United States | PubMed | PubMed | |
| 11799 | PHS HHS | United States | PubMed | PubMed | |
| K02DA00326 | NIDA NIH HHS | United States | K02DA000326 | PubMed and NIH | NIH RePORTER |
| K05AA00133 | NIAAA NIH HHS | United States | K05AA000133 | PubMed and NIH | NIH RePORTER |
| K05AA014715 | NIAAA NIH HHS | United States | K05AA014715 | PubMed and NIH | NIH RePORTER |
| K23AA00329 | NIAAA NIH HHS | United States | K23AA000329 | PubMed and NIH | NIH RePORTER |
| U10AA11715 | NIAAA NIH HHS | United States | U10AA011715 | PubMed and NIH | NIH RePORTER |
Trials6
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00006206 | COMBINE (Acamprosate/Naltrexone) | Results | Yes | ClinicalTrials.gov |
| NCT00762710 | Study of the Medication Prazosin for Alcohol Dependence | Background | ClinicalTrials.gov | |
| NCT01087736 | Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy | Background | ClinicalTrials.gov | |
| NCT01638377 | Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers | Background | ClinicalTrials.gov | |
| NCT02330419 | Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM) | Background | ClinicalTrials.gov | |
| NCT04356274 | Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health Care | Background | ClinicalTrials.gov |
Comments and corrections4
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 16670416 | Evidence-based treatments for alcohol dependence: new results and new questions. | https://conductscience.org/library/papers/16670416 | PubMed |
| Comment in | 17032980 | Pharmacotherapy and behavioral intervention for alcohol dependence. | https://conductscience.org/library/papers/17032980 | PubMed |
| Comment in | 17032981 | Pharmacotherapy and behavioral intervention for alcohol dependence. | https://conductscience.org/library/papers/17032981 | PubMed |
| Comment in | 17264268 | Naltrexone increased abstinence and reduced heavy drinking during treatment. | https://conductscience.org/library/papers/17264268 | PubMed |
Cited by794
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,299 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42897429 | Orbitofrontal-ventral striatal coupling: A model of the neurobehavioral architecture of craving in substance use disorders. | Cogn Affect Behav Neurosci | 2026 | https://conductscience.org/library/papers/42897429 | PubMed |
| 42851418 | Inflammatory cytokines as predictors of therapeutic response to valproate in patients with comorbid alcohol use disorder and bipolar disorder. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42851418 | PubMed |
| 42804611 | Therapies for alcohol use disorder in alcohol-associated hepatitis clinical trials: Integrated trial design with a composite clinical outcome as the primary endpoint. | Hepatology | 2026 | https://conductscience.org/library/papers/42804611 | PubMed |
| 42752444 | Efficacy of A Virtual Agent-Based Digital Intervention (Echo App V2.0) for Patients With Alcohol Use Disorder: Randomized Controlled Trial. | J Med Internet Res | 2026 | https://conductscience.org/library/papers/42752444 | PubMed |
| 42658589 | Fifteen-month drinking reductions in a randomized clinical trial of cognitive-behavioral and mindfulness-based treatments and a matched nontreatment-seeking community sample. | J Consult Clin Psychol | 2026 | https://conductscience.org/library/papers/42658589 | PubMed |
| 42602047 | Opioid antagonist treatment in alcohol use disorder: extinction, reward memory, and the possible importance of timing. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42602047 | PubMed |
| 42577825 | Pharmacologic management of metabolic and alcohol-associated liver disease. | Metab Target Organ Damage | 2026 | https://conductscience.org/library/papers/42577825 | PubMed |
| 42569123 | Clinical characteristics and drinking patterns among treatment-seeking patients with alcohol use disorder in Japan from the ALPS-J nationwide prospective cohort study. | PCN Rep | 2026 | https://conductscience.org/library/papers/42569123 | PubMed |
| 42550725 | Emergency Department-initiated Naltrexone for Alcohol Use Disorder: Association with Recidivism. | West J Emerg Med | 2026 | https://conductscience.org/library/papers/42550725 | PubMed |
| 42248693 | Optimizing outpatient pharmacologic treatment for veterans with alcohol use disorder using an academic detailing approach for primary care providers in the United States Department of Veterans Affairs: A retrospective quasi-experimental study. | Addiction | 2026 | https://conductscience.org/library/papers/42248693 | PubMed |
| 42144942 | Missing Data Sensitivity Analyses for Alcohol Research. | Alcohol Clin Exp Res (Hoboken) | 2026 | https://conductscience.org/library/papers/42144942 | PubMed |
| 42135584 | Implementation of a Hospital-Based Screening and Treatment Program for Unhealthy Alcohol Use. | J Gen Intern Med | 2026 | https://conductscience.org/library/papers/42135584 | PubMed |
| 42094871 | Craving for a Robust Methodology: A Systematic Review of Machine Learning Algorithms on Substance-Use Disorders Treatment Outcomes. | Int J Ment Health Addict | 2026 | https://conductscience.org/library/papers/42094871 | PubMed |
| 42072636 | Melatonergic Receptors Mediate Reduction in Ethanol Consumption in Wistar Rats. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072636 | PubMed |
| 42063598 | A neuroimmune framework for understanding adolescent stress and risk of alcohol misuse. | Brain Behav Immun Health | 2026 | https://conductscience.org/library/papers/42063598 | PubMed |
| 41958092 | Participant Demographic and Baseline Drinking Factors Can Predict Alcohol Use Disorder Pharmacotherapy Clinical Trial Completion and Drinking Outcomes. | Alcohol Clin Exp Res (Hoboken) | 2026 | https://conductscience.org/library/papers/41958092 | PubMed |
| 41948736 | Fenofibrate restores glutamatergic and dopaminergic homeostasis in the nucleus accumbens and reduces alcohol relapse in rats. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41948736 | PubMed |
| 41947825 | Targeting Multiple Gut-Brain Pathways in Obesity: Rationale for Combination Pharmacotherapy. | Obes Sci Pract | 2026 | https://conductscience.org/library/papers/41947825 | PubMed |
| 41821994 | Comparative Effectiveness of Naltrexone Formulations in Alcohol Use Disorder: An Updated Meta-Analysis. | Psychopharmacol Bull | 2026 | https://conductscience.org/library/papers/41821994 | PubMed |
| 41760917 | Modulating the endocannabinoid system in alcohol use disorder: A translational systematic review and meta-analysis of preclinical and human studies. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/41760917 | PubMed |
Drugs2
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| ACAMPROSATE | CHEMBL1201293 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1201293 | ChEMBL |
| NALTREXONE | CHEMBL19019 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL19019 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16670409
GET https://conductscience.org/api/papers/v1/16670409/authors?page=2